Last $38.30 USD
Change Today -0.27 / -0.70%
Volume 500.8K
MYGN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Walter A. Gilbert Ph.D.

Founding Scientist, Vice Chairman and Member of Compensation Committee, Myriad Genetics Inc.
AgeTotal Calculated CompensationThis person is connected to 43 board members in 6 different organizations across 11 different industries.

See Board Relationships
82$372,354

Background*

Dr. Walter A. Gilbert, Ph.D., also known as Wally, is the General Partner of BioVentures Investors LLC. Dr. Gilbert has been holding this position since 2001 and served as the Managing Director. He is the Executive Officer at Biogen Idec Ma Inc. Dr. Gilbert co-founded Biogen N.V. in 1978 and served as the Chief Executive Officer and Chairman of Biogen from 1981 to 1985. As the Chief Executive Officer, he oversaw the company’s Initial Public Offering in 1983 and played ...

Read Full Background

Corporate Headquarters*

320 Wakara Way
Salt Lake City, Utah 84108

United States

Phone: 801-584-3600
Fax: 801-584-3640

Board Members Memberships*

Co-founder, Director and Member of Scientific Advisory Board
Member of Scientific Advisory Board
Former Chairman
Director
Co-Founder and Chairman
Director
1992-Present
Founding Scientist, Vice Chairman and Member of Compensation Committee
1996-Present
Chairman
1996-N/A
Co-Founder
2000-N/A
Director
2009-2009
Former Director

Education*

MA
Harvard University
BS
Harvard University
PhD
University of Cambridge

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options120,000
Unexercisable Options30,000
Total Number of Options150,000

Total Compensation*

Total Annual Cash Compensation$67,500
Total Calculated Compensation$372,354
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MYGN:US $38.30 USD -0.27

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Joseph A. Chlapaty Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Advanced Drainage Systems, Inc.
$454.2K
Peer M. Schatz Chairman of Management Board, Chief Executive Officer and Managing Director
Qiagen NV
$1.5M
Marc D. Grodman M.D.Founder, Chairman, Chief Executive Officer, President and Managing Director
Bio-Reference Laboratories Inc.
$1.2M
Russell Cummings Chief Executive Officer, Executive Director, and Member of Investment Committee
Imperial Innovations Group plc
210.0K GBP
Kimberly J. Popovits Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$600.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MYRIAD GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.